CompletedPhase 4

The Montefiore Metoclopramide Study

United States289 participantsStarted 2007-05

Plain-language summary

Metoclopramide is a dopamine antagonist frequently used for the treatment of nausea, vomiting, and migraine headaches in Emergency Departments. However, little research has focused on the optimal dose of metoclopramide for treatment of nausea in the emergency department. We propose a randomized, double-blind, placebo controlled trial to investigate the optimal dose of metoclopramide for treatment of nausea.

Who can participate

Age range21 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * primary or secondary complaints of nausea/vomiting * age 21-65 Exclusion Criteria: * pregnancy * use of anti-histamine or dopamine antagonist as outpatient and/or within last 24 hours of presentation * previous adverse reaction to study medications * use of opioid medications prior to study start time within that ED visit

What they're measuring

Nausea Scale

Timeframe: 60 minutes

Trial details

NCT IDNCT00475306

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-02

Results submitted2011-07-11

View on ClinicalTrials.gov More Nausea trials